Avner Lushi

EasyGlide is providing practitioners a clear choice for improved visualization during gastroenterological procedures. The ClearPath™ Irrigation and Evacuation System with ClearSite Technology™ is revolutionizing how GI endoscopy is performed by providing a clinically informative view of the GI tract even in suboptimal conditions. The result is greater control without having to change procedural technique. EasyGlide is a privately held company dedicated to improving gastroenterology through its proprietary, patented technologies. Its vision is to improve procedural visualization, making minimally invasive gastroenterological procedures, more successful, more consistent, and more efficient. Its first product, the ClearPath™ Irrigation and Evacuation System, improves visualization during colonoscopies.

EasyLap Ltd. is a privately held company dedicated to advancing laparoscopy through its proprietary, patented technologies. Its vision is to enable widespread use of laparoscopy through devices that shorten the learning curve, reduce laparoscopic procedure time, optimize technique, and minimize complications. Easy-Lap's first suite of products, the I-Mesh series, offers an intelligent path to laparoscopic success in hernia repair. The Company is founded by Eldar Samuel, Einat Duvdevany-Fabian, and Fabian Izhak in 2007 and is headquartered in Kfar Truman, Israel.

Tadir-gan Ltd. is a holding Israeli company that specializes in manufacturing machined and assembled aluminum and magnesium high-pressure die products through its subsidiaries.

THERAPiN Ltd. engages in the development, growth, and manufacture of cannabis products for medical purposes. Its products include medical grade inflorescences, pre-rolled cigarettes, and medical grade cannabis oil. The company was founded on September 26, 2017 and is headquartered in Ramot Menashe, Israel.

Guangzhou InMode Medical Technology Ltd. engages in the medical research and experimental development activities. Its business scopes include biomedical technology research, management of non-licensed medical devices, and import and export businesses. The company was founded on September 23, 2016 and is headquartered in Guangzhou, China.

Monaliza Medical Ltd. develops a genetic test platform enabling prenatal genetic screening in Transcervical Cell samples taken in the first trimester of pregnancy. It develops non-invasive prenatal screening and diagnostic tests for early detection of fetal abnormalities. The company was founded in 2004 and is headquartered in Ra'anana, Israel